PPD/APPLIED BIOSCIENCE MERGER TO CREATE THIRD LARGEST CRO with contract research "net revenue in excess of $150 mil.," the companies reported following signing of the merger agreement June 20. Total net revenue for the combined company will be $200 mil. The combined company will keep the Pharmaceutical Product Development name and headquarters in Wilmington, N.C. Applied Bioscience, a holding company headquartered in Arlington, Va., comprises the CRO Pharmaco International, the investigative site Chicago Center for Clinical Research, and an environmental sciences group, Environ, offering chemical and environmental health risk assessment.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
New members of the CDC’s Advisory Committee on Immunization Practices suggested concerns beyond myocarditis, questioning whether test-negative observational studies are giving an incorrect picture of effectiveness.
The plan could curtail a period of pricing flexibility for newer subcutaneous versions of important oncology drugs.
Lawyers explain how changes to rules around drug advertising and promotional activities under the EU pharma reform package could impact companies operating in the bloc, with one legal expert advising companies to “monitor developments closely.”
